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Summary
Notification and laboratory data for the period January 1985 -
December 1988 were compared in order to estimate: (I) the
minimum level of under-reporting of hepatitis B; and (i/) the
consistency of the level of under-reporting, both regiorially
and nationally. Ratios between hepatitis B notifications and
positive hepatitis B laboratory tests (reporting ratios) were
calculated to quantify the discrepancy between these para-
meters. There were at least 7 positive hepatitis B laboratory
results for each notified case of hepatitis B during each year
studied. The differences between the national reporting ratios
for each of the study years were small, indicating that
nationally the level of reporting of hepatitis B is fairly consis-
tent. The Cape region had the highest and most constant
level of hepatitis B reporting compared with other regions.
We conclude that the national incidence of hepatitis B is at
least 7 times higher than that calculated from notification
data. Further, the inter-year analysis of hepatitis B notification
data to identify trends nationally and within the Cape region
is valid. However, caution is called for when comparing the
incidence rates between regions due to inter-region and
region-specific inter-year inconsistencies in reporting levels.
S Air Med J 1991; 79: 242-244.
The endemic nature of hepatitis B, with its concomitant high
mortality rate, was clearly identified by the incisive analysis of
national surveillance data even before the causative agent was
discovered. l Voluntary notification by health care providers,
known as passive surveillance, exists in some form in many
countries including South Africa.
An analysis of hepatitis B notification data by Viljoen2
revealed an average incidence rate of 0,73 per 100000 popula-
tion per annum in South Mrica for the period 1980 - 1987.
Furthermore, the highest incidence rate for hepatitis B was
found in the Cape Province.
Under-reporting in passive surveillance systems may lead to
inaccurate and unreliable notification data. 3 Notwithstanding
this problem, and assuming that the level of under-reporting
remains reasonably constant, data.generated by passive surveil-
lance systems can be useful in identifying trends. 3 To obtain
any meaningful incidence rates and trends from notification
data, it is important to estimate both the level of under-
.reporting and the consistency of these levels.
Another, generally under-utilised, source of surveillance
data comes from routine diagnostic laboratories. Referring to
public health, research and diagnostic laboratories at universi-
ties, the Centers for Disease Control and large hospitals in the
USA, Evans4 concluded that the '... consolidation and
utilization of information "from these various sources represent
the best ongoing method for surveillance of viral infections'.
The National Institute for Virology (NIV) collates routine
diagnostic hepatitis B data from 7 virology laboratories (the
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NIV and 6 virology laboratories attached to medical schools)
in South Mrica that offer this serological test, while the
Department of National Health and Population Development
collates all notifications of hepatitis B. Laboratory and notifica-
tion data are published monthly in the South African Virus
Laboratories: Surveillance Bulletin and Epidemiological Com-
ments, respectively.
The objectives of this study were to estimate the minimum
level of under-reporting of hepatitis B and to investigate the




The number of hepatitis B notifications for 1985,5 1986,6
19877 and 19888 were collated from published data. The data
for 1985 and 1986 represent notifications received and com-
puterised by 21 February 1986 and 20 February 1987, respec-
tively, while the data for 1987 and 1988 represent notifications
received and computerised by 12 July 1988 and 25 Juiy 1989,
respectively. .
Information on the number of positive hepatitis B laboratory
tests was collated from 44 issues (February 1985 - January
1989) of the South African Virus Laboratories: Surveillance
Bulletin. 9
The virology laboratories that contribute to the South
African Virus Laboratories: Surveillance Bulletin were
requested to provide guestimates of the proportions of their
reported positive results, which are repeat specimens, in an
attempt to obtain a crude estimate of the extent of double
counting in the laboratory data.
Analysis of data
The data were collated and analysed for each· 12-month
interval (January- December) for the 4-year period from
January 1985 to December 1988 according to geographically
defined regions. Since the two sources presented data for
differing geographically defined areas, comparable regions were
produced by aggregating data from existing categories.
With regard to hepatitis B notifications, data for the Natal
region were obtained by combining available data from Natal,
KwaZulu and Transkei. Similarly, data for the Orange Free
State (OFS) region were obtained by aggregating data from
OFS and Qwa-Qwa; those for the Transvaal region from
southern Transvaal, northern Transvaal, Gazankulu, Lebowa,
KaNgwane, Venda, Bophuthatswana and KwaNdebele; and·
those for the Cape region from eastern Cape, western Cape,
northern Cape and Ciskei.
With regard to the number of positive hepatitis B laboratory
results, the data for the Transvaal region were obtained by
combining data from the NIV, the Medical University of
Southern Mrica and the University of Pretoria, while the data
for the Cape region were obtained by aggregating the data
from the Universities of Cape Town and Stellenbosch. The
data for the Natal and OFS regions were obtained without
further collation.
Laboratory data were adjusted using the mean of the guesti-:
mates of the extent of double counting. Ratios between hepa-
titis B notifications and positive hepatitis B laboratory results
(reporting ratios) were calculated at both regional and national
levels to quantify the difference between the numbers of
notifications and positive serological tests.
Results
The guestimates of the proportion of double counting in the
laboratory data varied from negligible to 20%. The mean of the
guestimates was 10%.
Nationally, there was 1 notified caseof hepatitis B for every
7 positive hepatitis B laboratory results for the entire study
period. The national and regional reporting ratios for each
yc;:ar from 1985 to 1988 are shown in Table I.
The annual national reporting ratios varied between 1:7 and
1:9. At the regional level, the reporting ratios ranged from 1:5
to 1:9 in the OFS, 1:7 to 1:13 in Natal and 1:14 to 1:25 in the
Transvaal. The reporting ratio for the Cape was 1:3 in each
year studied. With regard to inter-region differences for the
entire 4-year period, the Transvaal reporting ratio was substan-
tially lower than all other regions and the Cape reporting ratio
was the highest.
Discussion
There were 7 times more positive hepatitis B laboratory results
than hepatitis B notifications during each of the 4 years studied.
This ratio provides a crude estimate of the level of under-
reporting of hepatitis B, which is similar to that found in a
study of reporting rates in the USA, where a review of the
discharge records of 11 hospitals in Washington, DC, revealed
that only 11%of cases of viral hepatitis were notified. IQ
The differences between the national reporting ratios for
each of the study years were small indicating that nationally
the level of reporting of hepatitis B is fairly consistent. Hence,
analysis of the hepatitis B notifications could provide useful
information on trends in the incidence of this disease.
Regional comparisons demonstrated marked differences in
the level of under-reporting. The Cape region had the highest
and most constant level of hepatitis B reporting, while the
Transvaal region had the lowest level of reporting. The Trans-
vaal and ;Natal regions had erratic levels of reporting with a
SAMJ VOL 79 2 MAR 1991 243
distinctly different ratio for at least one of the years within the
study period.
The marked differences in the level of reporting between
regions may spuriously create considerable inter-region dif-
ferenct:.s in incidence rates. It is essential therefore that dif-
ferences in the reporting level be taken into consideration
when comparing, between regions, the hepatitis B incidence
rates calculated from notification data.
These conclusions must be tempered by consideration of the
accuracy of the notification and laboratory data and the validity
of the comparisons between these two sources of data.
Accuracy of notification data
The accuracy of notification data may have been influenced
by the dates on which the data were produced, the so-called
'run-dates'. Although the run-dates differed for each of the
years ·because of the unavailability of standardised annual data,
there was an interval of at least 8 weeks between the end of
each year and the run-date. After this period the increase in
the number of notifications was small, mainly affecting the
data for November and December. In our opinion, the use of
data that were not generated on a standard run-date would
affect our results, at most, minimally.
Accuracy of laboratory data
The problem of 'double counting', i.e. repeat positive labora-
tory results on patients found to be positive by previous
serology, was partially overcome by adjusting the laboratory
data using the guestimates of double counting. Until all viro-
logy laboratories develop mechanisms to identify patients who
have had positive hepatitis B serology before, little can be
done to circumvent this limitation. Since this study uses these
data to develop crude estimates of the level of under-reporting,
this rough method of adjusting the laboratory data can be
considered adequate.
Data from privately owned laboratories and the South Afri-
can Institute for Medical Research were unavailable and could
not be included in the analysis. If these data were included the
number of positive hepatitis B laboratory tests would be greater
than those reported here and this would have the effect of
increasing the reporting ratios. The reporting ratios derived
from the available data are therefore minimum estimates.
TABLE I. RATIOS OF HEPATITIS B NOTIFICATIONS TO POSITIVE HEPATITIS B LABORATORY TESTS FOR EACH
REGION FROM 1985 TO 1988
Region Data source 1985 1986 1987 1988 Total
Notified cases 85 71 128 107 391
Natal Laboratory test 787 889 887 886 3449
Reporting ratio 1:9 1:13 1:7 1:8 1:9 -
Notified cases 9 12 9 14 44
OFS Laboratory test 50 59 77 108 294
Reporting ratio 1:6 1:5 1:9 1:8 1:7
Notified cases 79 81 58 78 296
TVL Laboratory test 1212 1389 1433 1 125 5159
Reporting ratio 1:15 1:17 1:25 1:14 1:17
Notified cases 158 171 221 258 808
Cape Laboratory test 548 526 688 876 2638
Reporting ratio 1:3 1:3 1:3 1:3 1:3
Notified cases 331 335 416 457 1 539
National Laboratory test 2597 2863 3085 2995 11540
Reporting ratio 1:8 1:9 1:7 1:7 1:7
The number of positive laboratory tests were adjusted by 10% to reduce the effect of double counting.
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At regional level, falsely lowered reporting ratios may result
from a laboratory that produces a substantial number of
positive hepatitis B results on patients from a region other
than the one in which it is located. While this does occur, it
involves only a few specimens (S. Johnson, NIV - personal
communication).
The number of laboratories in any region will have an
influence on the number of positive results obtained from that
region and hence on the reporting ratio. We were unable to
quantify this effect and therefore did not attempt to take it
into account when comparing inter-region reporting ratios.
Validity of comparisons between notification
and laboratory data
The regional categories created by aggregating existing cate-
gories of data may not be strictly comparable. This problem
may influence inter-region, but not inter-year, reporting ratio
comparisons slightly.
Since the different types of viral hepatitis infections are
clinically indistinguishable, serology is essential for diagnostic
purposes and clinicians with access to laboratory facilities tend
to utilise them. Hence, the laboratory data include a large
proportion of the clinical cases of hepatitis B being seen in the
health care service that .has good access to virology laboratory
facilities. This is the basis of the comparisons between the
laboratory and notification data.
There is an important caveat in the interpretation of these
comparisons, viz. laboratory data also include results from
individuals who do not have clinical hepatitis but are routinely
screened for hepatitis B, e.g. health care workers, patients on
haemodialysis and organ or cell donors.
The presence of immunoglobulin M antibody to hepatitis B
core antigen could be used as a marker to identify patients
with acute!l and chronic 12 hepatitis. It is, however, not
uniformly present in all patients with acute hepatitis 13 and the
test is not routinely done or reported by all virology labora-
tories. This marker is, therefore, not very useful for the
purposes of this study. Furthermore, there are no other readily
available mechanisms or markers to differentiate between hepa-
titis B carriers and patients with clinical hepatitis in the
laboratory data.
Legislative requirements for notification of hepatitis B do
not draw a distinction between clinical disease and asympto-
matic carriers; the decision on whether to notify asymptomatic
hepatitis B carriers rests with the doctor (H. G. V. Kiistner-
personal communication). Sixty doctors, constituting a
random sample of doctors from King Edward VIII Hospital,
Durban, were questioned and 93% said that they would report
_an asymptomatic hepatitis B carrier (unpublished data). It is
therefore-legitimate to compare notifications with laboratory
data even though the latter would include persons who are
asymptomatic.
Conclusion
T(} the best of our knowledge, the methods for estimating the
level of under-reporting that were devised for this study have
not been reported previously. These methods are particularly
useful because they utilise readily available sources of data and
may, with some constraints, be applicable to other notifiable
conditions, such as poliomyelitis and rabies.
Unfortunately, the methods cannot be extended to all noti-
fiable conditions because laboratory data are either not available
or do not approximate the number of cases of the disease seen
by the health care service, as is the case with measles, where
laboratory tests are not required for diagnosis.
We conclude that the national incidence of hepatitis B is at
least 7 times higher than that calculated from notification data.
Further, the inter-year analysis of hepatitis B notification data
to identify trends nationally and within the Cape region are
valid. However, caution is called for when comparing incidence
rates between regions due to inter-region and region-specific
inter-year inconsistencies in reporting levels.
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